Snego Pharmaceuticals Private Limited

Snego Pharmaceuticals Private Limited - business services in Via-Danpur, Odisha, India. FY 2026 financials & compliance.
CIN U74999OR2018PTC028200 Incorporated 11 January 2018 ROC Cuttack HQ Via-Danpur, Odisha, India
Active Private Limited Company business services DPIIT Startup
Data last updated
Revenue · FY 2023
₹3.21 Lakh
▼ 23% YoY
Net profit · FY 2023
₹1,420
Net margin 0.4%
EBITDA · FY 2023
₹1.08 Lakh
EBITDA margin 33.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
GST registrations
1
None active

About Snego Pharmaceuticals Private Limited

Data last updated:

Snego Pharmaceuticals Private Limited is a private limited company based in Via-Danpur, Odisha, India, recognised as a startup by DPIIT. It operates in the diversified business activities segment of the business services sector. It was incorporated on 11 January 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U74999OR2018PTC028200. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Ashwin Kumar Mohanty and Gourabananda Routray.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No 341 Gokulananda Routray House At – Tirinia Po – Indalo, Via – Danpur, Odisha, India – 754210.

As per the financials filed for FY 2023, the company reported a revenue of ₹3.21 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹1,420 (net margin 0.4%) and EBITDA of ₹1.08 Lakh (EBITDA margin 33.6%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years.

Company details

CIN U74999OR2018PTC028200
Registration Number 028200
Incorporation Date 11 January 2018
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
DPIIT Recognition Recognised Startup

Recognitions & Rankings of Snego Pharmaceuticals

DPIIT recognised startup Government of India
Startup India

Contact details

Snego Pharmaceuticals Private Limited's registered office is in Via-Danpur, Odisha. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No 341 Gokulananda Routray House At – Tirinia Po – Indalo, Via – Danpur, Odisha, India – 754210
  • Industry
    Business Services, Miscellaneous Business Activities, Other Services

To see the full contact details of Snego Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Snego Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Snego Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Snego Pharmaceuticals Private Limited, buy the company report.

Financials of Snego Pharmaceuticals Private Limited

FY 2023 filings available

Snego Pharmaceuticals Private Limited reported revenue of ₹3.21 Lakh (down 23% YoY) for FY 2023.

Revenue · FY 2023
₹3.21 Lakh ▼ 23%
Net profit · FY 2023
₹1,420 margin 0.4%
EBITDA · FY 2023
₹1.08 Lakh margin 33.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 38%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 9%

Revenue has declined at a compounded annual rate (CAGR) of 38% over three years, including a 23% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.08 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1,420
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin33.6%
Net Profit Margin0.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Snego Pharmaceuticals Private Limited, buy the company report.

Board of directors of Snego Pharmaceuticals Private Limited

Snego Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashwin Kumar MohantyDirector07 Sep 20206 Years 1 MonthsCurrent
Gourabananda RoutrayDirector11 Jan 20188 Years 9 MonthsCurrent
Gyanananda RoutrayDirector11 Jan 20188 Years 9 MonthsCurrent

Peer comparison

Snego Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Fysan Pharmaceuticals Private Limited₹3.22 Lakh (FY 2020)-62.0%Pune, Maharashtra, India
Prickom Pharmaceuticals Private Limited₹3.22 Lakh (FY 2025)34.0%Lucknow, Uttar Pradesh, India
Snego Pharmaceuticals Private Limitedthis company₹3.21 Lakh (FY 2023)₹1,4200.4%-23.0%Via-Danpur, Odisha, India
Vaishnav Pharmaceuticals Private Limited₹3.21 Lakh (FY 2024)Nagpur, Maharashtra, India
Aloves Med Pharmaceuticals Private Limited₹3.2 Lakh (FY 2024)-66.0%Nalasopara West, Maharashtra, India
Metkind Pharmaceuticals Private Limited₹3.19 Lakh (FY 2025)Gorkhpur, Uttar Pradesh, India

To see the full peer comparison of Snego Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Snego Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Snego Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Snego Pharmaceuticals Private Limited, buy the company report.

Recent activity

Snego Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Ashwin Kumar Mohanty was appointed as Director on 07 Sep 2020.

AGM
Snego Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Snego Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack.
Appointed
Ashwin Kumar Mohanty was appointed as Director.
Appointed
Gourabananda Routray was appointed as Director.
Appointed
Gyanananda Routray was appointed as Director.
Incorporation
11 Jan 2018
Snego Pharmaceuticals Private Limited was registered on 11 Jan 2018 with Roc Cuttack & aged 8 years 9 months as per MCA records.

Frequently asked questions

Snego Pharmaceuticals is an active private limited company based in Via-Danpur, Odisha, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 11 January 2018 (8+ years old) and is registered under CIN U74999OR2018PTC028200.

Snego Pharmaceuticals has 3 current directors:

The latest financial statements of Snego Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.

No. Snego Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Snego Pharmaceuticals is U74999OR2018PTC028200. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Snego Pharmaceuticals was incorporated on 11 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Cuttack.

The peers of Snego Pharmaceuticals by revenue are Fysan Pharmaceuticals Private Limited, Prickom Pharmaceuticals Private Limited, Vaishnav Pharmaceuticals Private Limited, Aloves Med Pharmaceuticals Private Limited, Metkind Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Ashwin Kumar Mohanty was appointed as Director on 07 Sep 2020. Gourabananda Routray was appointed as Director on 11 Jan 2018. Gyanananda Routray was appointed as Director on 11 Jan 2018.

Yes, Snego Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

The registered office of Snego Pharmaceuticals is at Plot No 341 Gokulananda Routray House At – Tirinia Po – Indalo, Via – Danpur, Odisha, India – 754210.

Snego Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.